Maturi, R., A. Glassman, K. Josic, A. Antoszyk, B. Blodi, L. Jampol, D. Marcus, D. Martin, M. Melia, H. Salehi-Had, C. Stockdale, O. Punjabi, and J. Sun. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor Vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial. JAMA Ophthalmol., 2021, p. Epub PubMed Text.
Abstract
Importance: The role of anti-vascular endothelial growth factor injections for the management of nonproliferative diabetic retinopathy (NPDR) without center-involved diabetic macular edema (CI-DME) has not been clearly established.